发明名称 Topical analgesic lotion
摘要 Technologies are described for a formulation and production of a formulation. The methods may comprise depositing a non-steroidal anti-inflammatory drug (NSAID) compound into a chamber. The methods may comprise depositing a muscle relaxant into the chamber. The methods may comprise depositing a calcium channel blocker into the chamber. The methods may comprise depositing a general anesthetic into the chamber. The methods may comprise depositing a local anesthetic into the chamber. The methods may comprise milling and mixing the NSAID compound, the muscle relaxant, the calcium channel blocker, the general anesthetic, and the local anesthetic into a powder. The methods may comprise adding a solvent with the powder. The methods may comprise mixing the solvent with the powder to form a solution. The methods may comprise adding a base cream to the solution. The methods may comprise mixing the base cream and the solution to form the formulation.
申请公布号 US9592215(B2) 申请公布日期 2017.03.14
申请号 US201615229434 申请日期 2016.08.05
申请人 Synergistic Therapeutics, LLC 发明人 Salce, Jr. Anthony H.;Greenwood William F.;Misir Shivsankar
分类号 A61K31/195;A61K31/135;A61K31/16;A61K31/196;A61K31/197;A61K31/137;A61K31/167;A61K9/00 主分类号 A61K31/195
代理机构 Moritt Hock & Hamroff LLP 代理人 Moritt Hock & Hamroff LLP ;Rubin, Esq. Steven S.
主权项 1. A formulation comprising: 5 to 10 weight percent of a non-steroidal anti-inflammatory drug (NSAID); 5 to 10 weight percent of a muscle relaxant; 0.01 to 0.05 weight percent of a calcium channel blocker; 0.005 to 0.010 weight percent of a general anesthetic; and 2 to 10 weight percent of a local anesthetic.
地址 Naples FL US